NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Sangui Biotech International Inc (HM: SBH)
SBH Technical Analysis
1
As on N/A SBH STOCK Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
SBHSTOCK Price
Open | N/A | Change | Price | % |
High | N/A | 1 Day | N/A | N/A |
Low | N/A | 1 Week | N/A | N/A |
Close | N/A | 1 Month | N/A | N/A |
Volume | N/A | 1 Year | N/A | N/A |
52 Week High N/A | 52 Week Low N/A |
HM Germany Most Active Stocks
WDI | 0.02 | 0.00% |
WDI | 0.02 | 0.00% |
WDI | 0.02 | 0.00% |
WDI | 0.02 | 0.00% |
WDI | 0.02 | 0.00% |
OSR | 51.60 | -0.39% |
OSR | 51.60 | -0.39% |
OSR | 51.60 | -0.39% |
OSR | 51.60 | -0.39% |
OSR | 51.60 | -0.39% |
HM Germany Top Gainers Stocks
HM Germany Top Losers Stocks
SBH Daily Charts |
SBH Intraday Charts |
Whats New @ Bazaartrend |
SBH Free Analysis |
|
SBH Important Levels Intraday
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE |
SBH Forecast December 2024
4th UP Forecast | |
3rd UP Forecast | |
2nd UP Forecast | |
1st UP Forecast | |
1st DOWN Forecast | |
2nd DOWN Forecast | |
3rd DOWN Forecast | |
4th DOWN Forecast |
SBH Weekly Forecast
4th UP Forecast | |
3rd UP Forecast | |
2nd UP Forecast | |
1st UP Forecast | |
1st DOWN Forecast | |
2nd DOWN Forecast | |
3rd DOWN Forecast | |
4th DOWN Forecast |
SBH Forecast2024
4th UP Forecast | |
3rd UP Forecast | |
2nd UP Forecast | |
1st UP Forecast | |
1st DOWN Forecast | |
2nd DOWN Forecast | |
3rd DOWN Forecast | |
4th DOWN Forecast |
Sangui Biotech International Inc ( HM Germany Symbol : SBH )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SBH Other Details
Segment | EQ | |
Market Capital | 7056910.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
SBH Address
SBH Latest News
SBH Business Profile
Sangui Biotech International, Inc., through its subsidiary, Sangui BioTech GmbH, develops hemoglobin-based artificial oxygen carriers for use as blood additives, blood volume substitutes, and variant products. The company's artificial oxygen carriers provide oxygen transport in humans in the event of acute and/or chronic lack of oxygen due to arterial occlusion, anemia, or blood loss, as well as chronic wounds. It also offers nano formulations for the regeneration of skin, including skin moisturization and enhanced skin elasticity; Chitoskin wound pads for supporting wound healing; and Hemospray wound spray, a medical product that is used for the healing of chronic wounds. The company sells its wound spray products under the Granulox brand name primarily in Europe and Mexico; and cosmetics products through internet shop. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany. Address: BleichenbrUecke 9, Hamburg, Germany, 20354
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service